40745-44-6

Basic information

• Product Name: 1-Acenaphthenamine
• Synonyms: 1-Acenaphthenamine;1,2-Dihydroacenaphthylene-1-amine;Acenaphthen-1-amine;1,2-dihydroacenaphthylen-1-aMine;1-aMinoacenaphthene;Acenaphthen-1-ylamine
• CAS NO: 40745-44-6
• Molecular Formula: C₁₂H₁₁N
• Molecular Weight: 169.22
• Mol File: 40745-44-6.mol
• Article Data: 2

Chemical Properties

• Melting Point: 81 ºC
• Boiling Point: 288.52°C (rough estimate)
• Flash Point: 173.9 °C
• Appearance: /
• Density: 1.187
• Vapor Pressure: 0.000119mmHg at 25°C
• Refractive Index: 1.5785 (estimate)
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 1-Acenaphthenamine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Acenaphthenamine(40745-44-6)
• EPA Substance Registry System: 1-Acenaphthenamine(40745-44-6)

Safety Data

• Hazardous Substances Data: 40745-44-6(Hazardous Substances Data)

Usage

General Description

1-Acenaphthenamine, also known as acenaphthene-1-amine, is a chemical compound with the molecular formula C12H11N. It is a white to off-white powder that is insoluble in water but soluble in organic solvents. 1-Acenaphthenamine is used in the synthesis of pharmaceuticals and organic compounds. It is a primary aromatic amine, which means it contains an amino group directly attached to an aromatic ring. This chemical is also used as a curing agent for epoxy resins, as a corrosion inhibitor, and as an intermediate in the production of dyes and antioxidants. While it has potential medicinal applications, it is also important to handle this compound with caution due to its potential hazards if not used properly.

InChI:InChI=1/C12H11N/c13-11-7-9-5-1-3-8-4-2-6-10(11)12(8)9/h1-6,11H,7,13H2

Upstream product

• 5088-53-9 1(2H)-acenaphthylenone oxime 
• 64-19-7 acetic acid 
• 6306-07-6 1-acenaphthenol 
• 2235-15-6 1(2H)-acenaphthylenone 
• 86-87-3 naphth-1-yl acetic acid 
• 5121-00-6 naphthalen-1-yl-acetyl chloride 

Downstream Products

• 254097-76-2 1-acenaphthen-1-yl-4-phenylamino-piperidine-4-carbonitrile 
• 228246-85-3 (RS)-1-(acenaphthen-1-yl)-4-(p-tolylamino)-piperidine-4-carbonitrile 
• 228246-82-0 (RS)-1-(acenaphthen-1-yl)-4-(m-tolylamino)-piperidine-4-carbonitrile 
• 228246-83-1 (RS)-1-(acenaphthen-1-yl)-4-(3-methoxy-phenylamino)-piperidine-4-carbonitrile 
• 228246-84-2 (RS)-1-(acenaphthen-1-yl)-4-(4-methoxy-phenylamino)-piperidine-4-carbonitrile 
• 254097-82-0 (RS)-4-(4-fluoro-phenylamino)-1-(acenaphthen-1-yl)-piperidine-4-carbonitrile 
• 254097-81-9 (RS)-4-(4-chloro-phenylamino)-1-(acenaphthen-1-yl)-piperidine-4-carbonitrile 
• 228246-81-9 (RS)-1-(acenaphthen-1-yl)-4-(3-chloro-phenylamino)-piperidine-4-carbonitrile 
• 254097-80-8 (RS)-4-(3-fluoro-phenylamino)-1-(acenaphthen-1-yl)-piperidine-4-carbonitrile 
• 247925-20-8 8-Acenaphthen-1-yl-1-(4-fluoro-phenyl)-1,3,8-triaza-spiro[4.5]decan-4-one 

Relevant articles and documents

REMEDY FOR SLEEP DISTURBANCE

The present invention has been made based on the finding that a compound acting on the ORL-1 receptor as an agonist acts as a non-photic entrainment factor, and advances the circadian rhythm phase, and provides a novel therapeutic agent for a sleep disorder such as circadian rhythm sleep disorder, more particularly, an agent for the prophylaxis and/or treatment of a sleep disorder, which contains an ORL-1 receptor agonist, and a novel compound useful as such agent for the prophylaxis and/or treatment.